Abstract
Azathioprine (AZA) is widely used to maintain clinical remission of Crohn’s disease. AZA is also important as a steroidsparingagent in steroid-dependent and active Crohn’s disease. Bone marrow suppression is common adverse effect ofAZA. We report a case of a 16-year-old male patient who was diagnosed as Crohn’s disease with involvement of terminalileum and colon; he experienced clinical and endoscopic remission of Crohn’s disease following improvement of AZAinduced life-threatening myelosuppression and pancreatitis.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
